Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy

被引:10
|
作者
Mason, Josh [1 ,2 ]
Henry, Ann [1 ,3 ]
Bownes, Peter [1 ]
机构
[1] Leeds Canc Ctr, Leeds, W Yorkshire, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Univ Leeds, Leeds, W Yorkshire, England
关键词
In vivo dosimetry; Prostate brachytherapy; DOSE-RATE BRACHYTHERAPY; VERIFICATION; CANCER;
D O I
10.1016/j.radonc.2020.04.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Routine real time in vivo dosimetry (IVD) is performed in HDR prostate brachytherapy to independently verify dose delivery. This study investigates impact of position uncertainty on error detection thresholds for IVD. Methods: IVD is implemented using a microMOSFET placed centrally in the prostate using an additional needle. 144 IVD measurements were made for 15 Gy or 19 Gy single fraction treatments. Needle insertion and treatment planning used real-time trans-rectal ultrasound. Source-MOSFET position thresholds of +/- 1, +/- 2 and +/- 3 mm were used to calculate per-needle and total plan error detection thresholds for the measured dose using an uncertainty analysis based on the treatment plan data. Results: The median dose difference from 144 total plan measurements was -5.2% (range +7.4% to - 17.3%). 3 plans measured outside the total plan error detection threshold for position threshold +/- 1 mm, no plans measured outside the total plan error detection threshold for larger position thresholds. For 2233 individual needle measurements, for position thresholds of +/- 1 mm, +/- 2mm and +/- 3 mm the number of needles outside the per-needle error detection threshold was 103, 25 and 10 respectively and the number of treatments that would have required interruption based on these thresholds for real-time IVD was 66, 16 and 8 respectively. Conclusion: IVD in HDR prostate brachytherapy using a microMOSFET provides a high level of confidence that we are correctly delivering the planned dose to our patients. A +/- 2-3 mm position threshold gives an appropriate balance between error detection and avoiding unnecessary treatment interruptions. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [21] In vivo dosimetry in brachytherapy of prostate cancer
    Kawczynska, M.
    Bulski, W.
    Czyzew, B.
    Garmol, D.
    Gruszczynska, E.
    Kasprowicz, A.
    Krol, M.
    Kulik, A.
    Lyczek, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S465 - S465
  • [22] Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors
    Poder, Joel
    Carrara, Mauro
    Howi, Andrew e
    Cutajar, Dean
    Bucci, Joseph
    Rosenfeld, Anatoly
    BRACHYTHERAPY, 2019, 18 (05) : 711 - 719
  • [23] HDR prostate brachytherapy plan robustness and its effect on in-vivo source tracking error thresholds: A multi-institutional study
    Poder, Joel
    Koprivec, Dylan
    Dookie, Yashiv
    Howie, Andrew
    Cutajar, Dean
    Damato, Antonio L.
    Cote, Nicolas
    Petasecca, Marco
    Bucci, Joseph
    Rosenfeld, Anatoly
    MEDICAL PHYSICS, 2022, 49 (06) : 3529 - 3537
  • [24] Dosimetry comparison between HDR and permanent implant prostate brachytherapy
    Wang, X
    MEDICAL PHYSICS, 2004, 31 (06) : 1881 - 1881
  • [25] THE INFLUENCE OF DOSIMETRY ON ACUTE URINARY TOXICITY IN HDR PROSTATE BRACHYTHERAPY
    El-Bared, Nancy
    Desrashodian, Talar
    Wakil, Georges
    Mondat, Marise
    Berbiche, Djamal
    Jolicoeur, Marjorie
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S53 - S53
  • [26] Errors detection in HDR brachytherapy using an in vivo dosimeter with real-time positional tracking information
    Tho, Daline
    lavallee, Marie--ClauDe
    Beaulieu, Luc
    MEDICAL PHYSICS, 2021, 48 (08) : 4673 - 4674
  • [27] In Vivo Dosimetry for HDR Brachytherapy Using a Scintillating Fiber Dosimeter
    Therriault-Proulx, F.
    Villeneuve, M.
    Martin, A.
    Gingras, L.
    Beddar, S.
    Beaulieu, L.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [28] HDR brachytherapy boost for prostate: Evaluation of prostate volume impact on dosimetry and toxicity
    Lavallee, M.
    Beaulieu, L.
    Despres, P.
    Martin, A. G.
    Foster, W.
    Vigneault, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S26 - S26
  • [29] US-probe integrated MOSkin detectors for rectal wall in vivo dosimetry in HDR prostate brachytherapy
    Carrara, M.
    Tenconi, C.
    Borroni, M.
    Cerrotta, A.
    Fallai, C.
    Cutajar, D.
    Lerch, M.
    Gambarini, G.
    Rosenfeld, A. B.
    Pignoli, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S75 - S75
  • [30] Real-time dosimetry for prostate brachytherapy using TRUS and fluoroscopy
    French, D
    Morris, J
    Keyes, M
    Salcudean, SE
    MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2004, PT 2, PROCEEDINGS, 2004, 3217 : 983 - 991